Showing results (51-60 of 203) with videos related to
Sort By:
Pageof 21
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1988
AntimetabolitesC J Allegra, J L Grem, G C Yeh, et al.Blood|November 1, 1975
Deoxycytidine kinase: properties of the enzyme from human leukemic granulocytesC N Coleman, R G Stoller, J C Drake, et al.Cancer Treatment Reports|March 1, 1978
Initial clinical trials of maytansine, an antitumor plant alkaloidB A Chabner, A S Levine, B L Johnson, et al.Cancer Treatment Reports|June 1, 1985
Competitive protein-binding assay for trimetrexateJ C Drake, C J Allegra, G A Curt, et al.Clinical Pharmacology and Therapeutics|July 1, 1979
Presence of 2,4-diamino-N10-methylpteroic acid after high-dose methotrexateR C Donehower, K R Hande, J C Drake, et al.Cancer Treatment Reports|July 1, 1977
Dose-dependent metabolism of methotrexate in man and rhesus monkeysS A Jacobs, R G Stoller, B A Chabner, et al.Cancer Treatment Reports|January 1, 1986
Potential roles for preclinical pharmacology in phase I clinical trialsJ M Collins, D S Zaharko, R L Dedrick, et al.The Journal of Clinical Investigation|February 1, 1976
7-Hydroxymethotrexate as a urinary metabolite in human subjects and rhesus monkeys receiving high dose methotrexateS A Jacobs, R G Stoller, B A Chabner, et al.Biochemical Pharmacology|March 16, 2010
Cytidine and deoxycytidylate deaminase inhibition by uridine analogsJ C Drake, K R Hande, R W Fuller, et al.Medicine|January 1, 1979
The clinical features of hepatic angiosarcoma: a report of four cases and a review of the English literatureG Y Locker, J H Doroshow, L A Zwelling, et al.Pageof 21